WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation, a discovery-stage biopharmaceutical company pursuing the development and potential commercialization of proprietary therapeutics based on RNA interference (RNAi) for the treatment of human diseases, today announced that it will hold a live webcast on Thursday March 13th at 11:00 AM EST. During this presentation the Company’s President and CEO, Tod Woolf, Ph.D., will present an overview on the company’s business and plans. RXi’s common stock has been approved for listing on the Nasdaq Capital Market under the symbol “RXII”, and is currently expected to begin trading on or about March 12th.
